Published online January 3, 2008
PEDIATRICS Vol. 121 Supplement January 2008, pp. S5-S14 (doi:10.1542/10.1542/peds.2007-1115B)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fishbein, D. B.
Right arrow Articles by Messonnier, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fishbein, D. B.
Right arrow Articles by Messonnier, N.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SUPPLEMENT ARTICLE


New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent

Daniel B. Fishbein, MDa, Karen R. Broder, MD, FAAPa, Lauri Markowitz, MDb and Nancy Messonnier, MDa

a National Center for Immunization and Respiratory Diseases
b National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

Adolescents in the United States now have the opportunity to receive new vaccines that prevent invasive meningococcal infections, pertussis (whooping cough), and cervical cancer. Except for their potential to cause serious illness, these infections could not be more different. Their incidence ranges from extremely low to quite high. Early clinical manifestations of infection range from none to life-threatening illness. Two of the vaccines are similar to those already in use, whereas 1 is completely new. In conjunction with the 4 vaccines previously recommended for adolescents (the tetanus and diphtheria booster, hepatitis B, measles-mumps-rubella, and varicella), the 3 new vaccines (meningococcal, human papillomavirus, and the tetanus-diphtheria-pertussis booster [which replaced the tetanus-diphtheria booster]) bring the number recommended for adolescents to 6. In this article, we describe key characteristics of the 3 new vaccines and infections they were designed to prevent. We also briefly discuss other vaccines recommended for all adolescents who have not already received them and new vaccines that are still under development.

Key Words: adolescent vaccination • new vaccines

Abbreviations: Td—tetanus and diphtheria toxoids • MMR—measles-mumps-rubella • AAP—American Academy of Pediatrics • ACIP—Advisory Committee on Immunization Practices • HPV—human papillomavirus • MPSV4—meningococcal polysaccharide vaccine • MCV4—meningococcal polysaccharide-protein conjugate vaccine • GBS—Guillain-Barré syndrome • TdaP—tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine • HbsAG—hepatitis B surface antigen

Accepted Aug 22, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
R. B. Neil and M. A. Apicella
Role of HrpA in Biofilm Formation of Neisseria meningitidis and Regulation of the hrpBAS Transcripts
Infect. Immun., June 1, 2009; 77(6): 2285 - 2293.
[Abstract] [Full Text] [PDF]